Select a Month...
Latest Press Releases
CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases
Initially, the alliance will develop treatment options for patients with two rare, life-threatening primary immunodeficiency diseases – Wiskott-Aldrich...
Seattle Children’s Research Institute: Building Cure Opens in Downtown Seattle to Accelerate Pediatric Research Discoveries
New building expands Seattle Children’s research campus to over 1.1 million square feet
Seattle Children’s Receives $20 Million Gift From Ballmer Family to Support Odessa Brown Children’s Clinic
Gift brings total raised for OBCC to nearly $90 million; Seattle Children’s aims to raise $125 million by 2021
UW Medicine and Seattle Children’s Appoint New Department of Pediatrics Chair, Associate Dean and Senior Vice President, Chief Academic Officer
Dr. Leslie R. Walker-Harding to assume position in February 2019
Seattle Children’s Opens New Clinic to Better Serve Families in North King, Snohomish, Whatcom and Skagit Counties
The new clinic will provide access to more than 18 pediatric specialty care services in the North Sound region
Solid Tumors Targeted in New CAR T-Cell Immunotherapy Trial
Open to children and young adults with relapsed or refractory disease, clinical trial extends immunotherapy to several types of EGFR-expressing solid tumors
Seattle Children’s Announces New Odessa Brown Children’s Clinic to Better Serve the Needs of the Community
Seattle Children’s new Odessa Brown Children’s Clinic will be located in South Seattle to increase access to healthcare for lower-income families who have...
Center for Infectious Disease Research to Join Seattle Children’s Research Institute
Combined scientific team will form largest pediatric infectious disease research program in the U.S.
Seattle Children’s Names Building in Honor of Friends of Costco
Friends of Costco has raised $125 Million for uncompensated care at Seattle Children’s
Seattle Children's Opens Immunotherapy Trial for Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain
CAR T-cell immunotherapy targeting HER2 protein on cancer cells aims to provide children and young adults who have limited treatment options with a second line...